Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

bioAffinity Technologies Inc. (BIAF)

  • Technical Exchange News
  • Feb. 15, 2025, 03:00 UTC
  • 26

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

Avinger Inc (AVGR)

  • Technical Exchange News
  • Feb. 15, 2025, 03:00 UTC
  • 27

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Applied Therapeutics (APLT)

  • Technical Exchange News
  • Feb. 15, 2025, 03:00 UTC
  • 29

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

PAVmed Inc (PAVMZ)

  • Technical Exchange News
  • Feb. 14, 2025, 19:17 UTC
  • 17

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Clearside Biomedical Inc (CLSD)

  • Technical Exchange News
  • Feb. 14, 2025, 19:16 UTC
  • 17

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

bioAffinity Technologies Inc. (BIAF)

  • Technical Exchange News
  • Feb. 14, 2025, 19:16 UTC
  • 17

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

Avinger Inc (AVGR)

  • Technical Exchange News
  • Feb. 14, 2025, 19:16 UTC
  • 19

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Applied Therapeutics (APLT)

  • Technical Exchange News
  • Feb. 14, 2025, 19:16 UTC
  • 18

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

BioLineRx Ltd. (BLRX)

  • Technical Exchange News
  • Feb. 14, 2025, 02:44 UTC
  • 18

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

BioAtla Inc (BCAB)

  • Technical Exchange News
  • Feb. 14, 2025, 02:44 UTC
  • 18

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text
  • Previous
  • 110
  • 111
  • 112
  • 113
  • 114
  • Next

Search

News categories

  • Technical Exchange News(9382)
  • Event(407)
  • SEC News(153225)
  • FDA Approval(8758)
  • Company Report(721)
  • Business News(104544)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin